Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Conserved Binding Sites01:49

Conserved Binding Sites

4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical knockoffs improve biomarker discovery from transcriptomic data.

Briefings in bioinformatics·2026
Same author

A Molecular Representation to Identify Isofunctional Molecules.

Molecular informatics·2025
Same author

Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Concomitant medication, comorbidity and survival in patients with breast cancer.

Nature communications·2024
Same author

A Network of 17 Microtubule-Related Genes Highlights Functional Deregulations in Breast Cancer.

Cancers·2023
Same author

Exploring isofunctional molecules: Design of a benchmark and evaluation of prediction performance.

Molecular informatics·2023
Same journal

Probing Charge-Controlled Inter-Domain Flexibility: Integrating Experimental and Coarse-Grained Approaches.

Journal of chemical information and modeling·2026
Same journal

FragScan: A Quantitative Fragment Scanning Strategy for Rational Drug Discovery.

Journal of chemical information and modeling·2026
Same journal

GeoPep: A Geometry-Aware Masked Language Model for Protein-Peptide Binding Site Prediction.

Journal of chemical information and modeling·2026
Same journal

Interaction Persistence-Based Identification of Key Binding Residues in the Cellular Retinol-Binding Protein 1 Complex.

Journal of chemical information and modeling·2026
Same journal

Tree-Guided Graph Neural Networks with Multilevel Optimization for Protein-Protein Interaction Prediction.

Journal of chemical information and modeling·2026
Same journal

ASO-RASAR: A Read-Across Framework for Predicting Antisense Oligonucleotide Gapmer Activity Across Target Genes.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Drug-Target Interactions Prediction at Scale: The Komet Algorithm with the LCIdb Dataset.

Gwenn Guichaoua1,2,3, Philippe Pinel1,2,3,4, Brice Hoffmann4

  • 1Center for Computational Biology (CBIO), Mines Paris-PSL, 75006 Paris, France.

Journal of Chemical Information and Modeling
|September 5, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces LCIdb, a large drug-target interaction dataset, and Komet, a scalable prediction pipeline. Komet outperforms deep learning methods for drug discovery and target identification.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.2K

Area of Science:

  • Computational chemistry and cheminformatics
  • Bioinformatics and computational biology
  • Drug discovery and development

Background:

  • Drug-target interactions (DTIs) prediction is crucial for drug discovery, aiding in target deorphanization and identification.
  • Existing DTI prediction methods often struggle with scalability and broad applicability across diverse molecular and protein spaces.
  • Developing large, high-quality datasets and efficient, scalable prediction algorithms are key challenges.

Purpose of the Study:

  • To address the challenges of building large DTI datasets and developing scalable prediction methods.
  • To introduce LCIdb, a comprehensive dataset for DTI prediction, expanding molecule space coverage.
  • To propose Komet, a novel, scalable DTI prediction pipeline designed for high performance on large datasets.

Main Methods:

  • Creation of LCIdb, a large, curated dataset of DTIs with extensive molecule and protein coverage.
  • Development of Komet, a DTI prediction pipeline utilizing a Kronecker interaction module and Nyström approximation.
  • Implementation of Komet with efficient computation, GPU parallelization, and quasi-Newton optimization for scalability.

Main Results:

  • Komet demonstrates superior scalability and prediction performance compared to state-of-the-art deep learning approaches.
  • The pipeline shows strong generalization capabilities on external datasets and scaffold hopping benchmarks.
  • LCIdb provides significantly broader molecule space coverage than existing public benchmarks.

Conclusions:

  • Komet offers an efficient and high-performing solution for large-scale DTI prediction in drug discovery.
  • The developed methods and datasets facilitate advancements in identifying novel drug-target relationships.
  • Open-source availability of Komet and datasets promotes further research and application in the field.